Deep androgen receptor suppression in prostate cancer exploits sexually dimorphic renal expression for systemic glucocorticoid exposure von Alyamani, M., Li, J., Patel, M., Taylor, S., Nakamura, F., Berk, M., Przybycin, C., Posadas, E.M., Madan, R.A., Gulley, J.L., Rini, B., Garcia, J.A., Klein, E.A., Sharifi, N.

Volltext

Impact of tumour volume on the potential efficacy of therapeutic vaccines von Gulley, J L, Madan, R A, Schlom, J

Volltext

Long-term follow-up of prostate cancer patients treated with vaccine and definitive radiation therapy von Kamrava, M, Kesarwala, A H, Madan, R A, Lita, E, Kaushal, A, Tsang, K-Y, Poole, D J, Steinberg, S M, Ferrara, T, Dahut, W, Schlom, J, Gulley, J L

Volltext

Radiation induced liver disease: A clinical update von Benson, R., Madan, R., Kilambi, R., Chander, S.

Volltext

Long-Term Survival and PSA Control with Radiation and Immunotherapy for Node Positive Prostate Cancer von Coleman, C. N., Kaushal, A., Madan, Ravi A., Tsang, Kwong Yok, Kamrava, M., Gulley, James L.

Volltext

Radiation induced heart disease: Pathogenesis, management and review literature von Madan, R., Benson, R., Sharma, D.N., Julka, P.K., Rath, G.K.

Volltext

Waldenstrom's macroglobulinemia evolving into acute lymphoblastic leukemia: a case report and a review of the literature von Madan, R A, Chang, V T, Yook, C, Baddoura, F K, Srinivas, S, Kasimis, B

Volltext

Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis von Cho, Michael H, Dr, McDonald, Merry-Lynn N, PhD, Zhou, Xiaobo, PhD, Mattheisen, Manuel, PhD, Castaldi, Peter J, MD, Hersh, Craig P, MD, DeMeo, Dawn L, MD, Sylvia, Jody S, MS, Ziniti, John, BS, Laird, Nan M, Prof, Lange, Christoph, Prof, Litonjua, Augusto A, MD, Sparrow, David, Prof, Casaburi, Richard, Prof, Barr, R Graham, MD, Regan, Elizabeth A, MD, Make, Barry J, Prof, Hokanson, John E, Prof, Lutz, Sharon, PhD, Dudenkov, Tanda Murray, MS, Farzadegan, Homayoon, Prof, Hetmanski, Jacqueline B, MS, Tal-Singer, Ruth, PhD, Lomas, David A, Prof, Bakke, Per, Prof, Gulsvik, Amund, Prof, Crapo, James D, Prof, Silverman, Edwin K, Prof, Beaty, Terri H, Prof

Volltext

A retrospective analysis of cardiovascular morbidity in metastatic hormone-refractory prostate cancer patients on high doses of the selective COX-2 inhibitor celecoxib von Madan, R A, Xia, Q, Chang, V T, Oriscello, R G, Kasimis, B

Volltext

(R)Evolutionary therapy: the potential of immunotherapy to fulfill the promise of personalized cancer treatment von Madan, Ravi A, Gulley, James L

Volltext

874PA phase I study of Ad5 PSA/MUC-1/brachyury vaccine in patients with metastatic castration resistant prostate cancer (mCRPC) von Bilusic, M, Madan, R A, Karzai, F H, McMahon, S, Donahue, R N, Strauss, J, Gatti-Mays, M E, Redman, J, Cordes, L M, Palena, C, Gabitzsch, E S, Jones, F R, Balint, J P, Soon-Shiong, P, Rabizadeh, S, Policard, M, Schlom, J, Gulley, J L

Volltext

Is it time to reevaluate definitive therapy in prostate cancer? von Madan, Ravi A, Shah, Avni A, Dahut, William L

Volltext

2013 consensus statement for early reperfusion and pharmaco-invasive approach in patients presenting with chest pain diagnosed as STEMI (ST elevation myocardial infarction) in an I... von Dalal, J J, Alexander, T, Banerjee, P S, Dayasagar, V, lyengar, S S, Kerkar, P G, Mullasari, A, Sathe, S P, Wander, G S

Volltext

Phase II clinical trial of cediranib in patients with metastatic castration‐resistant prostate cancer von Dahut, William L., Madan, Ravi A., Karakunnel, Joyson J., Adelberg, David, Gulley, James L., Turkbey, Ismail B., Chau, Cindy H., Spencer, Shawn D., Mulquin, Marcia, Wright, John, Parnes, Howard L., Steinberg, Seth M., Choyke, Peter L., Figg, William D.

Volltext

A phase I, open-label, multiple-ascending-dose trial to investigate the safety, tolerability, pharmacokinetics, biological, and clinical activity of M7824, a novel bifunctional fus... von Strauss, J, Heery, C, Schlom, J, Madan, RA, Lamping, E, Marte, J, Cordes, L, Lan, Y, Mahnke, L, Helwig, C, Lo, KM, Gulley, J

Volltext

Intraprostatic PSA-TRICOM vaccine administration in patients with locally recurrent prostate cancer von Heery, C. R., Pinto, P. A., Schlom, J., Tsang, K. Y., Madan, R. A., Poole, D., Vergati, M., Walter Rodriguez, B., Merino, M., Gulley, J. L.

Volltext

A phase I study of TRC105 (anti-CD105 monoclonal antibody) in metastatic castration-resistant prostate cancer (mCRPC) von Adelberg, D., Apolo, A. B., Madan, R. A., Gulley, J. L., Pierpoint, A., Kohler, D. R., Trepel, J. B., Steinberg, S. M., Figg, W. D., Dahut, W. L.

Volltext

Phase II trial of bevacizumab (A), lenalidomide (R), docetaxel (D), and prednisone (P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) von Huang, X., Ning, Y. M., Gulley, J. L., Kluetz, P. G., Adelberg, D., Mulquin, M., Madan, R. A., Bassim, C., Figg, W. D., Dahut, W. L.

Volltext

A randomized phase II study of flutamide with or without PSA-TRICOM in nonmetastatic castration-resistant prostate cancer (CRPC) von Bilusic, M., Gulley, J. L., Heery, C., Apolo, A. B., Arlen, P. M., Rauckhorst, M., McMahon, S., Dahut, W. L., Schlom, J., Madan, R. A.

Volltext

Intraprostatic vaccine administration in patients with locally recurrent prostate cancer von Heery, C., Pinto, P. A., Schlom, J., Tsang, K. Y., Madan, R. A., Poole, D., Vergati, M., Walter Rodriguez, B., Merino, M., Gulley, J. L.

Volltext